LESLEY HARCAR: Open Payments
NPI 1528399011 · GRAPEVINE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,974 in 166 payments from 20 companies in 2025. Trend: 2023 $3,021 · 2024 $2,808 · 2025 $2,974
Food & beverage: $2,879Education: $95
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $434 |
| Janssen Biotech, Inc. | 14 | $359 |
| UCB, Inc. | 12 | $274 |
| Arcutis Biotherapeutics, Inc. | 15 | $247 |
| E.R. Squibb & Sons, L.L.C. | 14 | $197 |
| Novartis Pharmaceuticals Corporation | 7 | $184 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $169 |
| GENZYME CORPORATION | 9 | $169 |
| PFIZER INC. | 9 | $158 |
| MAYNE PHARMA COMMERCIAL LLC | 21 | $134 |
Products named: TREMFYA, Bimzelx, SKYRIZI, Zoryve, DUPIXENT, Sotyktu, RINVOQ, CIBINQO.
Industry payments across TX — which companies pay providers there.
